Author Correction: 3-Phosphoinositide-dependent kinase 1 drives acquired resistance to osimertinib

Affiliations

• ¹ Department of Thoracic and Cardiovascular Surgery, The University of Texas MD Anderson Cancer Center, Houston, TX, USA. imeraz@mdanderson.org.
• ² Department of Thoracic and Cardiovascular Surgery, The University of Texas MD Anderson Cancer Center, Houston, TX, USA.
• ³ Department of Biostatistics, The University of Texas MD Anderson Cancer Center, Houston, TX, USA.
• ⁴ Department of Biostatistics, Graduate School of Public Health, Yonsei University, Seoul, Korea.
• ⁵ Department of Bioinformatics and Computational Biology, The University of Texas MD Anderson Cancer Center, Houston, TX, USA.
• ⁶ Department of Stem Cell Transplantation, The University of Texas MD Anderson Cancer Center, Houston, TX, USA.
• ⁷ Department of Biochemistry, Baylor College of Medicine, Houston, TX, USA.
• ⁸ Department of Medicine, University of California, San Francisco, San Francisco, CA, USA.
• ⁹ Helen Diller Family Comprehensive Cancer Center, University of California, San Francisco, San Francisco, CA, USA.
• ¹⁰ Department of Cellular and Molecular Pharmacology, University of California, San Francisco, San Francisco, CA, USA.
• ¹¹ University of California Davis Comprehensive Cancer Center, Sacramento, CA, USA.